These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33946483)

  • 1. Identification of Novel Fusion Transcripts in High Grade Serous Ovarian Cancer.
    Newtson A; Reyes H; Devor EJ; Goodheart MJ; Bosquet JG
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of DPP9 in gene fusions in serous ovarian carcinoma.
    Smebye ML; Agostini A; Johannessen B; Thorsen J; Davidson B; Tropé CG; Heim S; Skotheim RI; Micci F
    BMC Cancer; 2017 Sep; 17(1):642. PubMed ID: 28893231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ESRRA-C11orf20 is a recurrent gene fusion in serous ovarian carcinoma.
    Salzman J; Marinelli RJ; Wang PL; Green AE; Nielsen JS; Nelson BH; Drescher CW; Brown PO
    PLoS Biol; 2011 Sep; 9(9):e1001156. PubMed ID: 21949640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDKN2D-WDFY2 is a cancer-specific fusion gene recurrent in high-grade serous ovarian carcinoma.
    Kannan K; Coarfa C; Rajapakshe K; Hawkins SM; Matzuk MM; Milosavljevic A; Yen L
    PLoS Genet; 2014 Mar; 10(3):e1004216. PubMed ID: 24675677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel cyclin gene fusion transcripts in endometrioid ovarian carcinomas.
    Agostini A; Brunetti M; Davidson B; Göran Tropé C; Heim S; Panagopoulos I; Micci F
    Int J Cancer; 2018 Sep; 143(6):1379-1387. PubMed ID: 29633253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent BCAM-AKT2 fusion gene leads to a constitutively activated AKT2 fusion kinase in high-grade serous ovarian carcinoma.
    Kannan K; Coarfa C; Chao PW; Luo L; Wang Y; Brinegar AE; Hawkins SM; Milosavljevic A; Matzuk MM; Yen L
    Proc Natl Acad Sci U S A; 2015 Mar; 112(11):E1272-7. PubMed ID: 25733895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
    Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
    [No Abstract]   [Full Text] [Related]  

  • 8. CD133 Act as an Essential Marker in Ovarian Carcinogenesis.
    Ikram D; Masadah R; Nelwan BJ; Zainuddin AA; Ghaznawie M; Wahid S
    Asian Pac J Cancer Prev; 2021 Nov; 22(11):3525-3531. PubMed ID: 34837909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into the pathogenesis of serous ovarian cancer and its clinical impact.
    Levanon K; Crum C; Drapkin R
    J Clin Oncol; 2008 Nov; 26(32):5284-93. PubMed ID: 18854563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression profile of tight junction protein claudin 3 and claudin 4 in ovarian serous adenocarcinoma with prognostic correlation.
    Choi YL; Kim J; Kwon MJ; Choi JS; Kim TJ; Bae DS; Koh SS; In YH; Park YW; Kim SH; Ahn G; Shin YK
    Histol Histopathol; 2007 Nov; 22(11):1185-95. PubMed ID: 17647191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired FHIT expression characterizes serous ovarian carcinoma.
    Ozaki K; Enomoto T; Yoshino K; Fujita M; Buzard GS; Kawano K; Yamasaki M; Murata Y
    Br J Cancer; 2001 Jul; 85(2):247-54. PubMed ID: 11461085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [ZNF217 gene was detected in ovarian serous cystadenocarcinoma by fluorescence in situ hybridization].
    Zhong M; Li J; Ding YQ; Song LL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Dec; 23(6):665-7. PubMed ID: 17160949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of serous ovarian carcinoma using a multigene next generation sequencing cancer panel approach.
    Ab Mutalib NS; Syafruddin SE; Md Zain RR; Mohd Dali AZ; Mohd Yunos RI; Saidin S; Jamal R; Mokhtar NM
    BMC Res Notes; 2014 Nov; 7():805. PubMed ID: 25404506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma.
    Salvador S; Rempel A; Soslow RA; Gilks B; Huntsman D; Miller D
    Gynecol Oncol; 2008 Sep; 110(3):408-17. PubMed ID: 18597838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiles of ovarian low-grade serous carcinoma resemble those of fallopian tube epithelium.
    Qiu C; Lu N; Wang X; Zhang Q; Yuan C; Yan S; Dongol S; Li Y; Sun X; Sun C; Zhang Z; Zheng W; Kong B
    Gynecol Oncol; 2017 Dec; 147(3):634-641. PubMed ID: 28965696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
    Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
    J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. POSTN/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian cancer.
    Karlan BY; Dering J; Walsh C; Orsulic S; Lester J; Anderson LA; Ginther CL; Fejzo M; Slamon D
    Gynecol Oncol; 2014 Feb; 132(2):334-42. PubMed ID: 24368280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in gene expression during progression of ovarian carcinoma.
    Tapper J; Kettunen E; El-Rifai W; Seppälä M; Andersson LC; Knuutila S
    Cancer Genet Cytogenet; 2001 Jul; 128(1):1-6. PubMed ID: 11454421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube.
    Yang J; Zhou Y; Ng SK; Huang KC; Ni X; Choi PW; Hasselblatt K; Muto MG; Welch WR; Berkowitz RS; Ng SW
    BMC Cancer; 2017 Jun; 17(1):422. PubMed ID: 28623900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional perturbation of gene transcription is associated with intrachromosomal rearrangements and gene fusion transcripts in high grade ovarian cancer.
    Krzyzanowski PM; Sircoulomb F; Yousif F; Normand J; La Rose J; E Francis K; Suarez F; Beck T; McPherson JD; Stein LD; Rottapel RK
    Sci Rep; 2019 Mar; 9(1):3590. PubMed ID: 30837567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.